Related Experiment Videos
Characteristics, prevalence, and prognosis of postmyocardial infarction syndrome
Insights
Postmyocardial infarction syndrome occurred in 3.3% of patients after myocardial infarction. This syndrome is linked to more severe heart attacks, but prognosis is primarily dictated by underlying coronary heart disease severity.
Area of Science:
- Cardiology
- Internal Medicine
- Clinical Research
Background:
- Postmyocardial infarction syndrome (PMIS) is a recognized complication following myocardial infarction (MI).
- Understanding the characteristics and prognosis of PMIS is crucial for patient management.
Purpose of the Study:
- To investigate the incidence and clinical features of postmyocardial infarction syndrome.
- To compare the characteristics and outcomes of patients with and without PMIS.
- To evaluate the impact of corticosteroid treatment on PMIS prognosis.
Main Methods:
- A cohort of 1809 patients with myocardial infarction was retrospectively analyzed.
- Sixty patients who developed PMIS were identified and compared to matched controls without PMIS.
- Clinical data, infarct characteristics, and five-year mortality were assessed.
Main Results:
- The incidence of PMIS was 3.3% (60 patients).
- Patients with PMIS experienced larger and more complicated infarcts compared to controls.
- Five-year cumulative mortality was higher in the PMIS group (26%) versus controls (18%), though not statistically significant.
- Corticosteroid treatment did not appear to negatively impact PMIS prognosis.
Conclusions:
- Postmyocardial infarction syndrome is associated with more severe myocardial infarction.
- The prognosis of PMIS is predominantly determined by the severity of the underlying coronary heart disease.
- Further research may clarify the role of specific treatments in managing PMIS.
Abstract:
Among 1809 patients with myocardial infarction, 60 (3.3%) later developed a postmyocardial infarction syndrome. These 60 patients were compared with controls with myocardial infarction but without postmyocardial infarction syndrome. Cases with postmyocardial infarction syndrome had larger and more complicated infarcts than control subjects. Five year cumulative mortality was higher among cases (26%) than among control subjects (18%) but this difference was not statistically significant. Corticosteroid treatment did not adversely affect the prognosis of the postmyocardial infarction syndrome, which we conclude is mainly determined by the severity of the underlying coronary heart disease.